Johanna Marines, PharmD, Head of Preclinical team, will be presenting a groundbreaking research poster that highlight latest in vitro and in vivo results of our lead asset MQI-201 (Poster #4770).
This is a fantastic opportunity to learn about our most advanced first-in-class antibody program targeting TRPV6, a membrane ion channel protein.
Catch the poster presentation live on Tuesday, April 29 from 9:00 AM to 12:30 PM CST at Chicago McCormick Place Convention Center.
Interested in further discussion with Johanna and Sylvain Yon (CEO)?
Schedule a meeting with our team to discuss how our antibody discovery platform expedites highly developable and functional therapeutic antibodies.
AACR Annual Meeting
April 25-30, 2025
McCormick Place Convention Center
Chicago, Illinois, USA
